PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PTC Therapeutics Inc
PP&E Net Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
PP&E Net
$123.1m
CAGR 3-Years
0%
CAGR 5-Years
37%
CAGR 10-Years
34%
Abbvie Inc
NYSE:ABBV
PP&E Net
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Net
$5.3B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
14%
Amgen Inc
NASDAQ:AMGN
PP&E Net
$6.1B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Net
$1.8B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
9%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Net
$4.3B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
20%

See Also

What is PTC Therapeutics Inc's PP&E Net?
PP&E Net
123.1m USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's PP&E Net amounts to 123.1m USD.

What is PTC Therapeutics Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
34%

Over the last year, the PP&E Net growth was -31%.

Back to Top